Host-Pathogen Interaction Program, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Disease Intervention and Prevention Program, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Viruses. 2021 Sep 16;13(9):1850. doi: 10.3390/v13091850.
Recently discovered Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas13 proteins are programmable RNA-guided ribonucleases that target single-stranded RNA (ssRNA). CRISPR/Cas13-mediated RNA targeting has emerged as a powerful tool for detecting and eliminating RNA viruses. Here, we demonstrate the effectiveness of CRISPR/Cas13d to inhibit HIV-1 replication. We designed guide RNAs (gRNAs) targeting highly conserved regions of HIV-1. RfxCas13d (CasRx) in combination with HIV-specific gRNAs efficiently inhibited HIV-1 replication in cell line models. Furthermore, simultaneous targeting of four distinct, non-overlapping sites in the HIV-1 transcript resulted in robust inhibition of HIV-1 replication. We also show the effective HIV-1 inhibition in primary CD4 T-cells and suppression of HIV-1 reactivated from latently infected cells using the CRISPR/Cas13d system. Our study demonstrates the utility of the CRISPR/Cas13d nuclease system to target acute and latent HIV infection and provides an alternative treatment modality against HIV.
最近发现的成簇规律间隔短回文重复序列(CRISPR)/Cas13 蛋白是可编程的 RNA 指导的核糖核酸酶,可靶向单链 RNA(ssRNA)。CRISPR/Cas13 介导的 RNA 靶向已成为检测和消除 RNA 病毒的强大工具。在这里,我们证明了 CRISPR/Cas13d 抑制 HIV-1 复制的有效性。我们设计了针对 HIV-1 高度保守区域的向导 RNA(gRNA)。RfxCas13d(CasRx)与 HIV 特异性 gRNA 结合,可有效抑制细胞系模型中的 HIV-1 复制。此外,同时靶向 HIV-1 转录本中的四个不同的、不重叠的位点,可导致 HIV-1 复制的强大抑制。我们还表明,使用 CRISPR/Cas13d 系统可有效抑制原代 CD4 T 细胞中的 HIV-1 感染,并抑制潜伏感染细胞中 HIV-1 的重新激活。我们的研究证明了 CRISPR/Cas13d 核酸酶系统靶向急性和潜伏性 HIV 感染的实用性,并为 HIV 提供了一种替代治疗模式。